Literature DB >> 29682799

The differences between GluN2A and GluN2B signaling in the brain.

Yongjun Sun1,2, Yingge Xu1, Xiaokun Cheng3, Xi Chen1, Yinghua Xie1,2, Linan Zhang4, Long Wang5, Jie Hu6, Zibin Gao1,2,7.   

Abstract

The N-methyl-d-aspartate (NMDA) receptor, a typical ionotropic glutamate receptor, is a crucial protein for maintaining brain function. GluN2A and GluN2B are the main types of NMDA receptor subunit in the adult forebrain. Studies have demonstrated that they play different roles in a number of pathophysiological processes. Although the underlying mechanism for this has not been clarified, the most fundamental reason may be the differences between the signaling pathways associated with GluN2A and GluN2B. With the aim of elucidating the reasons behind the diverse roles of these two subunits, we described the signaling differences between GluN2A and GluN2B from the aspects of C-terminus-associated molecules, effects on typical downstream signaling proteins, and metabotropic signaling. Because there are several factors interfering with the determination of subunit-specific signaling, there is still a long way to go toward clarifying the signaling differences between these two subunits. Developing better pharmacology tools, such as highly selective antagonists for triheteromeric GluN2A- and GluN2B-containing NMDA receptors, and establishing new molecular biological methods, for example, engineering photoswitchable NMDA receptors, may be useful for clarifying the signaling differences between GluN2A and GluN2B.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  GluN2A; GluN2B; N-methyl-d-aspartate receptor; signaling differences

Mesh:

Substances:

Year:  2018        PMID: 29682799     DOI: 10.1002/jnr.24251

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Effects of datumetine on hippocampal NMDAR activity.

Authors:  Azeez Olakunle Ishola; Aminu Imam; Moyosore Salihu Ajao
Journal:  Toxicol Rep       Date:  2021-05-24

2.  Gamma-Decanolactone Alters the Expression of GluN2B, A1 Receptors, and COX-2 and Reduces DNA Damage in the PTZ-Induced Seizure Model After Subchronic Treatment in Mice.

Authors:  Fernanda Marcelia Dos Santos; Pricila Fernandes Pflüger; Leticia Lazzarotto; Mariana Uczay; Wesley Roberto de Aguida; Lisiane Santos da Silva; Fernanda Brião Menezes Boaretto; Jayne Torres de Sousa; Jaqueline Nascimento Picada; Iraci Lucena da Silva Torres; Patrícia Pereira
Journal:  Neurochem Res       Date:  2021-05-21       Impact factor: 3.996

Review 3.  Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.

Authors:  Menghan Niu; Xin Yang; Yuanyuan Li; Yanping Sun; Long Wang; Jing Ha; Yinghua Xie; Zibin Gao; Changzheng Tian; Le Wang; Yongjun Sun
Journal:  Cell Mol Neurobiol       Date:  2022-01-03       Impact factor: 5.046

Review 4.  Targeting neuronal nitric oxide synthase and the nitrergic system in post-traumatic stress disorder.

Authors:  Mohammad Amin Sadeghi; Sara Hemmati; Ehsan Nassireslami; Mojtaba Yousefi Zoshk; Yasaman Hosseini; Kourosh Abbasian; Mohsen Chamanara
Journal:  Psychopharmacology (Berl)       Date:  2022-08-27       Impact factor: 4.415

Review 5.  Dysfunction of the corticostriatal pathway in autism spectrum disorders.

Authors:  Wei Li; Lucas Pozzo-Miller
Journal:  J Neurosci Res       Date:  2019-11-22       Impact factor: 4.164

6.  Chronically altered NMDAR signaling in epilepsy mediates comorbid depression.

Authors:  Mohammad Amin Sadeghi; Sara Hemmati; Sina Mohammadi; Hasan Yousefi-Manesh; Ali Vafaei; Meysam Zare; Ahmad Reza Dehpour
Journal:  Acta Neuropathol Commun       Date:  2021-03-24       Impact factor: 7.801

7.  Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model.

Authors:  Idriss Ali Abdoulaye; Shan-Shan Wu; Enkhmurun Chibaatar; Da-Fan Yu; Kai Le; Xue-Jin Cao; Yi-Jing Guo
Journal:  Neural Plast       Date:  2021-04-23       Impact factor: 3.144

Review 8.  From bedside-to-bench: What disease-associated variants are teaching us about the NMDA receptor.

Authors:  Johansen B Amin; Gabrielle R Moody; Lonnie P Wollmuth
Journal:  J Physiol       Date:  2020-04-09       Impact factor: 5.182

9.  Anticonvulsant Action of GluN2A-Preferring Antagonist PEAQX in Developing Rats.

Authors:  Pavel Mares; Grygoriy Tsenov; Hana Kubova
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

Review 10.  A Review of Molecular Imaging of Glutamate Receptors.

Authors:  Jong-Hoon Kim; János Marton; Simon Mensah Ametamey; Paul Cumming
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.